88 related articles for article (PubMed ID: 17638668)
1. Anaplastic large cell lymphoma: a flow cytometric analysis of 29 cases.
Kesler MV; Paranjape GS; Asplund SL; McKenna RW; Jamal S; Kroft SH
Am J Clin Pathol; 2007 Aug; 128(2):314-22. PubMed ID: 17638668
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry.
Juco J; Holden JT; Mann KP; Kelley LG; Li S
Am J Clin Pathol; 2003 Feb; 119(2):205-12. PubMed ID: 12579990
[TBL] [Abstract][Full Text] [Related]
3. The expression of myeloid antigens CD13 and/or CD33 is a marker of ALK+ anaplastic large cell lymphomas.
Bovio IM; Allan RW
Am J Clin Pathol; 2008 Oct; 130(4):628-34. PubMed ID: 18794057
[TBL] [Abstract][Full Text] [Related]
4. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
5. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
Lai R; Medeiros LJ; Dabbagh L; Formenti KS; Coupland RW
Mod Pathol; 2000 Mar; 13(3):223-8. PubMed ID: 10757332
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL).
Mencía-Gutiérrez E; Gutiérrez-Díaz E; Salamanca J; Martínez-González MA
Int J Dermatol; 2006 Jun; 45(6):766-9. PubMed ID: 16796648
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric features of angioimmunoblastic T-cell lymphoma.
Chen W; Kesler MV; Karandikar NJ; McKenna RW; Kroft SH
Cytometry B Clin Cytom; 2006 May; 70(3):142-8. PubMed ID: 16572417
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric immunophenotyping of anaplastic large cell lymphoma.
Muzzafar T; Wei EX; Lin P; Medeiros LJ; Jorgensen JL
Arch Pathol Lab Med; 2009 Jan; 133(1):49-56. PubMed ID: 19123736
[TBL] [Abstract][Full Text] [Related]
10. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
11. CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall.
Perkins PL; Ross CW; Schnitzer B
Arch Pathol Lab Med; 1992 Nov; 116(11):1192-6. PubMed ID: 1359849
[TBL] [Abstract][Full Text] [Related]
12. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells.
Rust R; Blokzijl T; Harms G; Lim M; Visser L; Kamps WA; Poppema S; van den Berg A
J Pathol; 2005 Aug; 206(4):445-50. PubMed ID: 15920698
[TBL] [Abstract][Full Text] [Related]
13. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation.
Sasaki K; Sugaya M; Fujita H; Takeuchi K; Torii H; Asahina A; Tamaki K
Br J Dermatol; 2004 Jun; 150(6):1202-7. PubMed ID: 15214912
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping large B-cell lymphomas. Flow cytometric pitfalls and pathologic correlation.
Bertram HC; Check IJ; Milano MA
Am J Clin Pathol; 2001 Aug; 116(2):191-203. PubMed ID: 11488065
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
Rassidakis GZ; Sarris AH; Herling M; Ford RJ; Cabanillas F; McDonnell TJ; Medeiros LJ
Am J Pathol; 2001 Aug; 159(2):527-35. PubMed ID: 11485911
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: comparison with quantitative polymerase chain reaction.
Damm-Welk C; Schieferstein J; Schwalm S; Reiter A; Woessmann W
Br J Haematol; 2007 Aug; 138(4):459-66. PubMed ID: 17608768
[TBL] [Abstract][Full Text] [Related]
17. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
Hsu FY; Johnston PB; Burke KA; Zhao Y
Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
[TBL] [Abstract][Full Text] [Related]
18. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.
Weisenburger DD; Anderson JR; Diebold J; Gascoyne RD; MacLennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Armitage JO
Am J Hematol; 2001 Jul; 67(3):172-8. PubMed ID: 11391714
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
Rassidakis GZ; Goy A; Medeiros LJ; Jiang Y; Thomaides A; Remache Y; Cabanillas F; Sarris AH; Gilles F
Clin Cancer Res; 2003 Jun; 9(6):2213-20. PubMed ID: 12796388
[TBL] [Abstract][Full Text] [Related]
20. CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma.
Ait-Tahar K; Barnardo MC; Pulford K
Cancer Res; 2007 Mar; 67(5):1898-901. PubMed ID: 17332315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]